The tech behind NZ mammogram software firm Volpara’s global success

The tech behind NZ mammogram software firm Volpara’s global success
Around 42% of mammograms in the US touch Volpara software, says CEO Teri Thomas. (Image: Volpara)
Ben Moore
Volpara Health has become a staple name in the medtech industry as a software provider to detect breast cancer in mammogram images.The company was founded in 2009, listed on the Australian securities exchange (ASX) in 2016 and since then has seen strong growth.Chief executive Teri Thomas said 42% of mammograms in the United States touch at least one of Volpara’s products.“We doubled the number of big healthcare organisation engagements in the United States over the last year … from 10 to 20, so we've had record growth and...

More Health

Oceania forecasts sales lift as it targets debt
Property

Oceania forecasts sales lift as it targets debt

It said sales applications had lifted 23% between July and August.

Gregor Thompson 16 Sep 2025
F&P Healthcare urges Govt to shut patent loophole
Markets

F&P Healthcare urges Govt to shut patent loophole

The company says the current patent loophole threatens its NZ operations.

Michael Neilson 16 Sep 2025
F&P Healthcare one step closer to new Karaka campus
Policy

F&P Healthcare one step closer to new Karaka campus

Auckland Council has approved a request to rezone nearly 90ha going to hearings.

Oliver Lewis 12 Sep 2025
How RFK Jnr's Medicare reform could aid this NZ firm
Markets

How RFK Jnr's Medicare reform could aid this NZ firm

'Wild west' conditions hampered its US push. They could be changing.